MREO — MEREO BIOPHARMA GROUP PLC

Ownership history in EntryPoint Capital, LLC  ·  1 quarter on record

This page tracks every 13F SEC filing in which EntryPoint Capital, LLC reported a position in MEREO BIOPHARMA GROUP PLC (MREO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.07% (2025 Q4)
Avg. % of fund
0.07%
First filed
2025 Q4
Last filed
2025 Q4
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 INITIATED 400,700 — — 0.07% $167K $0.42
% of Fund (quarterly)    MREO price (monthly, adj. close)

Other funds also holding MREO

As of 2025 Q4 — sorted by position size

683 Capital Management, LLC 3Y 7Y 0.27% Tejara Capital Ltd 3Y 0.21% EcoR1 Capital, LLC 3Y 7Y 0.15% LUMINUS MANAGEMENT LLC 3Y 7Y 0.14% Rangeley Capital, LLC 0.13% Monaco Asset Management SAM 3Y 0.11% Rubric Capital Management LP 3Y 7Y 0.08% Knott David M Jr 3Y 0.06% Logos Global Management LP 3Y 0.05% DLD Asset Management, LP 3Y 7Y 0.02%
← Back to EntryPoint Capital, LLC Holdings